Biomarker Testing for Risk Assessment of Patients Suspected of Having Prostate Cancer

home / insights / biomarker-testing-for-risk-assessment-of-patients-suspected-of-having-prostate-cancer

Gerald Andriole, MD discusses pre-biopsy biomarker testing as a risk assessment tool in patients suspected of having prostate cancer, highlighting key advantages and reviewing available options and clinical data, and shares his clinical experience regarding implementation.

© 2024 MJH Life Sciences

All rights reserved.